Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lemez

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|March 1, 1991
[Occurrence of cells with ring-shaped nuclei in hairy cell leukemia]P Lemez
Neoplasma|January 1, 1990
Significance of lineage specific differentiation markers for complex classification of acute leukemias. II. Acute lymphoblastic leukemiasP Lemez
Casopis Lekaru Ceskych|October 26, 1990
[The importance of prognostic signs in malignant diseases]P Lemez
Neoplasma|January 1, 1990
Significance of lineage specific differentiation markers for complex classification of acute leukemias. I. Acute myeloid leukemiasP Lemez
Sbornik Lekarsky|November 1, 1989
[Acute leukemias in humans. I. Definition, etiology, and pathogenesis of acute leukemias. Classification of acute myeloid leukemia]P Lemez
Sbornik Lekarsky|January 1, 1990
[Human acute leukemia. II. Acute lymphoblastic leukemia. Complex classification of acute leukemia]P Lemez
Seminars in Oncology|October 13, 1998
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapyP Lemez, J Maresová
Neoplasma|September 10, 2005
Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patientsP Lemez, V Urbánek
Neoplasma|January 1, 1996
Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemiasP Lemez, J Maresová
Neoplasma|June 28, 2000
Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?P Lemez, J Gáliková, T Haas
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|March 1, 1991
[Occurrence of cells with ring-shaped nuclei in hairy cell leukemia]P Lemez
Neoplasma|January 1, 1990
Significance of lineage specific differentiation markers for complex classification of acute leukemias. II. Acute lymphoblastic leukemiasP Lemez
Casopis Lekaru Ceskych|October 26, 1990
[The importance of prognostic signs in malignant diseases]P Lemez
Neoplasma|January 1, 1990
Significance of lineage specific differentiation markers for complex classification of acute leukemias. I. Acute myeloid leukemiasP Lemez
Sbornik Lekarsky|November 1, 1989
[Acute leukemias in humans. I. Definition, etiology, and pathogenesis of acute leukemias. Classification of acute myeloid leukemia]P Lemez
Sbornik Lekarsky|January 1, 1990
[Human acute leukemia. II. Acute lymphoblastic leukemia. Complex classification of acute leukemia]P Lemez
Seminars in Oncology|October 13, 1998
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapyP Lemez, J Maresová
Neoplasma|September 10, 2005
Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patientsP Lemez, V Urbánek
Neoplasma|January 1, 1996
Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemiasP Lemez, J Maresová
Neoplasma|June 28, 2000
Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?P Lemez, J Gáliková, T Haas
Pageof 3